First, the efficient derivation of mature (Hb9+) MNs from embryonic stem cells is a sought-after goal in the understanding, and potential treatment, of motor neuron diseases: factors that enhance early steps in MN differentiation will therefore contribute to the derivation of MNs ex vivo. Here, MNX1 is linked to motor neuron disorder.